No Publication. Neither party may publicize or disclose to any third party, without the written consent of the other party, the terms of this Agreement. Without limiting the generality of the foregoing sentence, no press releases may be made without the mutual written consent of each party.
No Publication. XTL shall not publish or publicly present any information (a) relating to this Agreement, (b) any activities conducted under or in relation to this Agreement, or (c) relating to any Product, in all cases without the prior written consent of CUBIST. Neither Party shall make public use of the other Party’s name or identifying marks except as otherwise permitted under this Agreement, with the prior written consent of the other Party or as required by applicable law or regulation. CUBIST shall not use the names of Yeda, the Weizmann Institute of Science, Rehovot, or Xxxxxxxxx Xxxx Xxxxxxx in any advertising, sales literature, or promotional material unless (i) the prior written approval of Yeda thereto has been obtained or (ii) such use or disclosure is to governmental authorities for the purposes of obtaining approval or permission for the exercise of its license rights to any XTL Technology licensed to XTL pursuant to the XY Agreement or is in the fulfillment of any legal duty owed to any governmental authority or is required by applicable law. Nothing in this Section 8.3 shall limit XTL’s ability to apply for any patent protection.
No Publication. Except as, and only to the extent, -------------- otherwise expressly provided in Sections 2.2 and 5.2, Licensee shall not publish, disseminate or otherwise disclose or make available Confidential Information or Highly Confidential Information received hereunder to any person, firm or corporation without prior written consent of Licensor.
No Publication. Neither Party shall disclose, publicize or advertise in any manner the discussions or negotiations contemplated by this Agreement or any other Confidential Information without the prior written consent of the other Party, except as may be required by applicable law or regulation or by any competent judicial, governmental, supervisory or regulatory body (including without limitation, any stock exchange).
No Publication. 14.13 Severability.................................................. *Material has been omitted pursuant to a request for confidential treatment. Such material has been filed separately with the Securities and Exchange Commission. CONFIDENTIAL
No Publication. So long as this Agreement is in effect, no Party or any of its Affiliates shall issue or cause the publication of any press release or other announcement with respect to the terms or implementation of this Agreement without the prior consultation and approval of the other Party, except as may be required by law; provided that such approval shall not be unreasonably withheld or delayed. Any such publicity made in accordance with the terms of a joint communications program shall not require approval under this Section 30.09.
No Publication. Contractor will not make any press releases, public statements, or advertisement referring to this Agreement, or release any information relative to this Agreement or any Work authorized under this Agreement for publication, advertisement or any other purpose, without the prior written approval of the Owner.
No Publication. Neither party shall have the authority to make any statement, representation or commitment of any kind, or to take any action, which shall be binding on the other, without the prior consent of the other party. “Receiving Party” may not issue any press release or other publication with respect of the services and/or works provided to the “Disclosing Party”, without the “Disclosing Party” prior written consent.
No Publication. Neither party may publicize or disclose the terms of this Agreement to any third party without the written consent of the other Party. Without limiting the generality of the foregoing sentence, no press releases may be made without the mutual written consent of the Parties. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
No Publication. BIOCHEMIE shall not publish or present any BIOCHEMIE Know-How or any of the inventions claimed under any BIOCHEMIE Patents without the prior written consent of CUBIST, which consent shall not be unreasonably withheld. Nothing in this Section 4.3 shall limit BIOCHEMIE's ability to apply for any patent protection.
